Acurx Pharmaceuticals (ACXP) Earnings Analysis

Acurx Pharmaceuticals (ACXP) next reports earnings on 2026-08-14, consensus EPS -0.42 USD. Last quarter (2026-03-13) it beat with EPS -0.31 USD vs -1.01 USD est (+69.3%). It has beaten estimates in 5/6 recent quarters (83%). Trailing P/E -0.30.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does ACXP next report earnings?

Next earnings date2026-08-14
Consensus EPS estimate-0.42 USD
Revenue estimaten/a

ACXP earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-03-13-0.31 USD-1.01 USD+69.3%Beat
2025-11-12-1.23 USD-1.61 USD+23.6%Beat
2025-08-11-1.89 USD-2 USD+5.5%Beat
2025-05-12-2.2 USD-0.15 USD-1366.7%Miss
2025-03-17-0.16 USD-0.18 USD+11.1%Beat
2024-08-09-0.26 USD-0.28 USD+7.1%Beat

Beat rate: 5/6 (83%) over reported quarters with consensus data.

ACXP valuation and analyst view

Trailing P/E-0.30
Trailing EPS-5.00222 USD
Price / book0.31
Dividend yield0.00%
Market cap0.00B
Analyst consensusBuy (3 buy / 0 hold / 0 sell)

Related research pages

Frequently asked questions

When is Acurx Pharmaceuticals (ACXP)'s next earnings date?

Acurx Pharmaceuticals is next scheduled to report on 2026-08-14, with a consensus EPS estimate of -0.42 USD.

Did ACXP beat earnings last quarter?

In its 2026-03-13 report, ACXP posted EPS of -0.31 USD versus a -1.01 USD estimate — a beat of 69.3%.

What is ACXP's earnings track record?

Over the last 6 reported quarters with consensus data, ACXP beat estimates 5 times (83%).

What is ACXP's current P/E ratio and EPS?

ACXP trades at a trailing P/E of -0.30 on trailing EPS of -5.002219479653102 USD.

What do analysts rate ACXP?

Analyst consensus is "Buy" across 3 ratings (0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell).